GUTS · Fractyl Health, Inc. · Proposed Sales
$0.40
-0.05 (-11.13%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we have concluded that substantial doubt exists about our ability to continue as a going concern for at least one year after the date that these financial statements are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$77.30M
Shares
159.18M
Volume · Oct 2
3.06M
Avg daily vol (3M)
1.73M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-01-30 | JAY CAPLAN | Officer | 43,818 | 2025-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-30 | HARITH RAJAGOPALAN | Director, Officer | 111,920 | 2025-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-12 | JAY D CAPLAN | Officer | 65,000 | 2024-09-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings